Use of starting materials and intermediates collected from different sources in the manufacturing of non-recombinant biological medicinal products

Current effective version

PDF iconAdopted guideline

Reference numberEMA/CHMP/BWP/429241/2013
Effective from01/12/2013
KeywordsStarting materials, sourcing, intermediates, heparins, urine derived products, plasma derived medicinal products, manufacturing process
DescriptionThis document clarifies the definition of starting materials for specific groups of biologicals. It presents CHMP's current position on the use of variant processes in early manufacturing stages of these products.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft reflection paper

In operation: 01/12/2013-present

Published: 10/06/2013

Published: 31/05/2012

Related content

How useful was this page?

Add your rating